Xenetic Biosciences
XBIO
11 hedge funds and large institutions have $497K invested in Xenetic Biosciences in 2025 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
170% more capital invested
Capital invested by funds: $184K → $497K (+$313K)
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
10% more funds holding
Funds holding: 10 → 11 (+1)
6.22% more ownership
Funds ownership: 3.77% → 9.99% (+6.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$477K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$47.4K |
| 3 |
DS
DRW Securities
Chicago,
Illinois
|
+$44.1K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$12.8K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$9.24K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
S
Sachetta
Lynnfield,
Massachusetts
|
-$47.9K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$1.56K |
| 3 |
SS
SBI Securities
Tokyo,
Japan
|
-$16 |
| 4 |
Morgan Stanley
New York
|
-$3 |
XBIO Hedge Fund Activity: Q4 2025 in Review
11 of the 8,281 institutional investors tracked by Wall St. Rank reported a position in Xenetic Biosciences (XBIO) for Q4 2025, worth a combined $497K — up 170% from $184K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new XBIO positions and 3 closed out — a net gain of 1 holder — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $477K. The largest seller was Sachetta, exiting entirely with an estimated $47.9K sold.
- 11 institutional investors held Xenetic Biosciences (XBIO) as of Q4 2025, up from 10 in Q3 2025.
- Funds reported $497K of Xenetic Biosciences stock for Q4 2025, up 170% quarter-over-quarter.
- 4 funds opened new Xenetic Biosciences positions in Q4 2025 and 3 closed out, a net change of +1 holder.
- The largest Xenetic Biosciences buyer in Q4 2025 was Renaissance Technologies, an estimated $477K added.
- The largest Xenetic Biosciences seller in Q4 2025 was Sachetta, an estimated $47.9K sold.
Based on aggregated 13F filings for Q4 2025.